{"groups":[{"description":"Patients received 6 or 8 21-day cycles of CHOP (cyclophosphamide, hydroxydaunorubicin \\[doxorubicin\\], Oncovin \\[vincristine\\], prednisone) or CVP (cyclophosphamide, vincristine, prednisone) in combination with rituximab 375 mg/m\\^2 administered by intravenous (IV) infusion on Day 1 of each cycle.","id":"FG000","title":"Rituximab 375 mg/m^2"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"Physician decision to withdraw patient"},{"reasons":[{"groupId":"FG000","numSubjects":"8"}],"type":"Subject decision to withdraw"},{"reasons":[{"groupId":"FG000","numSubjects":"17"}],"type":"Various Reasons"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"451"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"425"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"26"}],"type":"NOT COMPLETED"}],"title":"Enrolled in Study"},{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"8"}],"type":"Adverse Event"},{"reasons":[{"groupId":"FG000","numSubjects":"5"}],"type":"Death"},{"reasons":[{"groupId":"FG000","numSubjects":"11"}],"type":"Eligibility criteria for Cycle 2 not met"},{"reasons":[{"groupId":"FG000","numSubjects":"7"}],"type":"Physician decision to withdraw patient"},{"reasons":[{"groupId":"FG000","numSubjects":"9"}],"type":"Subject decision to withdraw"},{"reasons":[{"groupId":"FG000","numSubjects":"13"}],"type":"Various Reasons"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"425"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"372"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"53"}],"type":"NOT COMPLETED"}],"title":"Received Cycle 1 Treatment"},{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"12"}],"type":"Adverse Event"},{"reasons":[{"groupId":"FG000","numSubjects":"6"}],"type":"Death"},{"reasons":[{"groupId":"FG000","numSubjects":"3"}],"type":"Disease progression"},{"reasons":[{"groupId":"FG000","numSubjects":"3"}],"type":"Lost to Follow-up"},{"reasons":[{"groupId":"FG000","numSubjects":"13"}],"type":"Physician decision to withdraw patient"},{"reasons":[{"groupId":"FG000","numSubjects":"6"}],"type":"Subject decision to withdraw"},{"reasons":[{"groupId":"FG000","numSubjects":"25"}],"type":"Various Reasons"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"372"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"304"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"68"}],"type":"NOT COMPLETED"}],"title":"Received Cycle 2 Treatment"}],"preAssignmentDetails":"Of 451 enrolled patients, 26 withdrew before receiving treatment and are not included in the Baseline Characteristics nor any of the Outcome Measures."}